Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Thrivewell Infusion is a healthcare services company specializing in the administration of specialty infusion and injectable therapies for patients with complex chronic conditions. The company operates state-of-the-art ambulatory infusion centers and provides home infusion services, focusing on therapeutic areas such as gastroenterology, neurology, rheumatology, and immunology. Their clinical team manages the administration of high-cost biologics and specialty drugs, including Remicade, Entyvio, Stelara, and IVIG. Thrivewell Infusion emphasizes a patient-centric approach, offering streamlined intake, insurance verification, and comfortable treatment environments to improve clinical outcomes and patient adherence.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Thrivewell Infusion.